Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure

Abstract

Increasing evidence supports the use of embolisation to treat pulmonary arteriovenous malformations (AVMs). Most pulmonary AVM patients have hereditary haemorrhagic telangiectasia (HHT), a condition that may be associated with pulmonary hypertension.